Our Team
Holistic thinkers, passionate about drug repurposing (DRPx) in dermatology — serving the needs of children and parents with cost-effective, efficacious and tolerable solutions for Atopic Dermatitis.
Pia Ullman
Director, Celfex AB
Pia Ullman is an experienced business leader with a track record in high-growth and dynamic industries, guiding Celfex's strategy and execution.
Dr. Adel El Messiry PhD
Advisor and Investor, OrchestratePharma GmbH
Dr. El Messiry is an Advisor of OrchestratePharma, focused on strategic partnership and fund raising for Celfex's clinical development programs.
Dr. Richard Bergström PhD
Strategic Advisor
Dr. Bergström is a co-founder of OrchestratePharma and a widely recognised leader in European pharma — a former Director-General of EFPIA and a long-standing advisor to global health bodies. He provides strategic and regulatory guidance to Celfex's development program.
Dr. Subbu Apparsundaram
Scientific Advisor
Dr. Apparsundaram is Partner & COO of Cellix Biosciences, originator of the Fexofenadine IP. A pharmacologist with prior roles at Roche and Vanderbilt University, he contributes deep molecular and translational science expertise to Celfex's program.
Our Parent Company
OrchestratePharma GmbH
OrchestratePharma GmbH is a Swiss-based company whose orchestrated approach to development involves partnership and co-development models that manifest in focused special purpose vehicles such as Celfex AB. The Fexofenadine formulation IP was licensed by OrchestratePharma and assigned to Celfex AB. OrchestratePharma has access to a broad portfolio of IP and welcomes investors and collaborators across other indications, including ophthalmology, oncology and neurology.